# AlphaFold vs. Traditional Protein Structure Prediction Tools AlphaFold predicts a protein's three-dimensional structure from its [amino acid sequence](/blog/guides/amino-acid-sequence) using deep neural networks trained on the [Protein Data Bank](/blog/guides/protein-data-bank) (PDB), while traditional tools such as MODELLER, SWISS-MODEL, I-TASSER, and Rosetta build models by borrowing, threading, or folding against known structures and physical energy functions. The rule of thumb is simple. If your target has homologs in sequence databases, start with AlphaFold2 (AF2) for the fastest route to an accurate monomeric model, and keep a traditional tool in the pipeline for template-based refinement, ligand-aware modeling, and quality assessment. If your target has no detectable homologs at all, no method is guaranteed, and the honest comparison between AlphaFold and older approaches becomes much closer than the headlines suggest. This guide is a [protein structure](/blog/guides/protein-structure) prediction tools comparison written for working bioinformaticians. It defines the traditional method classes, profiles the modern options, gives a side-by-side table, walks through realistic scenarios, and lists the mistakes that most often corrupt published models. ## What AlphaFold Actually Changed Protein structure prediction asks one question. Given a string of amino acids, what three-dimensional shape does the chain adopt? For fifty years the answer came from three method families, all anchored in experimentally solved structures. Then in 2020, at the CASP14 assessment (Critical Assessment of Structure Prediction, a biennial blind benchmark), AlphaFold2 achieved accuracy that reviewers described as a practical solution to the problem, and the 2023 Albert Lasker Basic Medical Research Award recognized the achievement of predicting, on a genomic scale, the three-dimensional arrangement of amino acids for the vast majority of proteins from sequence alone [1]. The scale of the change is easy to state. Structures predicted by AlphaFold and RoseTTAFold have become the standard starting point for many protein scientists, and commentators now describe the protein structure prediction problem as solved for the well-ordered core of most proteins, with new frontiers such as conformational sampling of [intrinsically disordered proteins](/knowledge/bioinformatics/intrinsically-disordered-proteins-and-computational-structural-classification) opening up [2]. A comprehensive review of computational models traces this progression from established modeling (homology, threading, ab initio) through the current generation of AI frameworks, including AlphaFold, AlphaFold2, AlphaFold3, and RoseTTAFold, and notes that AI techniques have also been integrated into older frameworks such as SWISS-MODEL, Rosetta, and I-TASSER [3]. Three ideas distinguish AF2 from everything that came before. 1. **Co-evolution at scale.** AF2 consumes a [multiple sequence alignment](/blog/guides/multiple-sequence-alignment) (MSA, a table of aligned homologous sequences that reveals which residue positions co-vary across evolution) and converts paired evolutionary statistics into inter-residue distance and orientation constraints [4]. 2. **End-to-end learning.** Instead of chaining separate steps (alignment, template search, fragment assembly, refinement), a single neural architecture refines the whole structure, iterating internal representations until geometry and constraints agree. 3. **Per-residue confidence.** Every prediction ships with a pLDDT score (predicted Local Distance Difference Test, a per-residue estimate of local accuracy on a 0 to 100 scale) and, for complexes, a PAE (predicted aligned error, an estimate of positional error between residue pairs). Older tools produced models with global scores but nothing close to this resolution of self-reporting. None of this made traditional tools obsolete. It changed where they sit in the workflow, which is exactly what the rest of this comparison maps out. ## The Traditional Toolkit, Defined on Its Own Terms Before comparing, you need clean definitions. Every method below still ships, still runs, and still solves problems AlphaFold does not. ### Homology (comparative) modeling Homology modeling builds a full-length model by copying structural fragments from one or more experimental structures (templates) of homologous proteins, guided by a sequence alignment. Accuracy tracks sequence identity to the template. Above roughly 50 percent identity, models are usually suitable for many downstream uses. Between 30 and 50 percent, loop and side-chain positions become uncertain. Below 20 to 30 percent, template misidentification becomes the dominant error source. MODELLER implements this by satisfaction of spatial restraints. You give it a target-template alignment. It converts the alignment into probability-density restraints on distances and dihedral angles, then finds the model that minimizes violations of those restraints plus a physical chemistry term. It remains the reference implementation that new pipelines build on. The AlphaMod pipeline, for example, couples AlphaFold2 with MODELLER specifically to improve AF2 output, and validates the combination on 72 target proteins previously used to assess AF2 independently [5]. SWISS-MODEL is the web-server equivalent, now with learned components integrated. Prostruc is a recent open-source Python tool that wraps Biopython, BLAST template identification, and ProMod3 structure generation into an automated homology pipeline with a two-stage validation process using TM-align (structural superposition, reporting RMSD and TM-score against a reference) and QMEANDisCo for model quality, aimed at researchers without deep modeling expertise [6]. Its existence is evidence that template-based modeling is still a live workflow, not a museum piece. Drug-discovery workflows illustrate why. A study designing inhibitors of the Kallikrein 11 (KLK11) protease predicted the protein's theoretical model with homology modeling protocols, validated the resulting structure with several server tools, and only then moved to active-site analysis and virtual screening with ROC analysis of binding-affinity scoring [7]. In ligand-bound contexts, a template with a bound ligand tells you where the pocket walls sit in a way a apo AlphaFold monomer does not. ### Threading (fold recognition) Threading asks a different question. If sequence similarity is weak, does the target nevertheless fit a known fold? Threading tools score the compatibility of a target sequence against a library of structural folds, using profiles, predicted secondary structure, and residue-environment preferences. I-TASSER is the classic hybrid. It threads fragments against the PDB, reassembles continuous fragments by Monte Carlo simulations, and refines with its own energy terms. In a head-to-head modeling study of the hepatitis C virus core protein (HCVcp), a viral capsid protein without adequate full-length templates, I-TASSER served as the template-based representative while MOE handled domain-based homology modeling by searching NCBI and the PDB for per-domain templates and assembling the modeled domains [8]. TemPred represents a newer twist on the same idea. Its authors point out that AlphaFold's contact-map approach effectively relies on fold recognition, and that AlphaFold structures are quite often not acceptable by structure-evaluation gold-standard parameters. TemPred therefore searches for templates using ordered local physicochemical property vectors (ProtPCV) rather than plain sequence identity, and found that templates generated this way were frequently better than those from conventional search engines, which the authors read as evidence that a combined approach produces better structural models [9]. ### Ab initio and physics-based modeling Ab initio (de novo) modeling folds a protein using physical and statistical energy functions with no template at all. Rosetta is the historical workhorse. Transform-restrained Rosetta (trRosetta) added predicted inter-residue restraints to the Rosetta energy landscape, and Robetta, the Baker-lab server, packages RoseTTAFold (a dual-track neural network relative of AF2) together with Rosetta-based refinement. In the HCVcp study mentioned above, the authors ran three neural-network de novo methods (AF2, Robetta-RoseTTAFold, and trRosetta) against two template-based tools (MOE and I-TASSER), then used molecular dynamics (MD) simulations to refine and compare the full-length and truncated structures [8]. That study is one of the cleanest published examples of a multi-tool protein structure prediction tools comparison on a single difficult target, and its lesson is that agreement across methods is itself informative. ### What the traditional toolkit still does that AlphaFold does not - **Ligands, cofactors, and bound states.** Template-based modeling inherits pocket geometry from templates solved with ligands bound. Standard AF2 predicts protein chains alone (AlphaFold3 extends to ligands and [nucleic acids](/blog/guides/nucleic-acids), but its monomeric protein-core accuracy story is the one benchmarked here). - **Loop and side-chain sampling under explicit energy.** Rosetta and MODELLER can repack and minimize specific regions against restraints you supply, which matters for engineering and for docking preparation. - **Multi-state modeling.** Homology modeling to different templates can capture distinct conformations. AlphaFold typically returns one dominant state per MSA configuration. - **Quality assessment frameworks.** A mature ecosystem of scoring tools (discussed below) grew up around traditional pipelines and remains the standard for judging AlphaFold output too. ## The Modern AI Toolbox ### AlphaFold2 AF2 is the reference point for every other tool in this comparison. Its input is a FASTA sequence. Its pipeline builds or retrieves an MSA, searches for structural templates, runs an Evoformer-based neural network with recycle iterations, and outputs a PDB file plus per-residue pLDDT and pairwise PAE arrays. The accuracy numbers are extraordinary. In a 2025 benchmark of 1,337 protein chains deposited in the PDB between July 2022 and July 2024, deliberately chosen so none overlapped AF2 training data, AlphaFold2 achieved the highest median TM-score (0.96), the highest median GDT-TS (94 percent), and the lowest median RMSD (1.30 Å), compared with ESMFold (TM-score 0.95, GDT-TS 90 percent, RMSD 1.74 Å) and OmegaFold (TM-score 0.93, GDT-TS 89 percent, RMSD 1.98 Å) [10]. For orientation, a TM-score above 0.5 generally indicates the same fold, and values near 0.95 indicate near-experimental accuracy for a globular domain. The weaknesses are equally well documented. Accuracy dropped in that benchmark for proteins lacking family annotations, leucine-rich repeats, and NMR-determined structures, and alignment-free methods unexpectedly excelled at de novo designed proteins [10]. The MSA dependence is the structural reason. Orphan proteins with no homologous sequences degrade AF2 performance sharply as MSA depth decreases, which is why dedicated benchmark datasets (Orphan62 for orphan proteins and Design204 for de novo designs) were constructed to evaluate MSA-enhanced and MSA-free methods fairly [4]. ### ESMFold and OmegaFold Both are alignment-free language-model predictors. ESMFold builds structure from the embeddings of a large protein language model (a network trained on hundreds of millions of unlabeled sequences to produce context-aware residue representations). OmegaFold combines a language model with a geometric folding module. In the benchmark above they ran 10 to 30 times faster than AF2 with a small accuracy penalty, and the authors concluded that the performance differences were negligible for many proteins, meaning faster alignment-free predictors are sufficient for numerous applications, and they shipped LightGBM classifiers using ProtBert embeddings and confidence outputs to predict when each tool would succeed [10]. Practically, this changes the calculus for large-scale screens. If you need structures for 50,000 metagenomic proteins overnight, the 10 to 30 times speed difference is the deciding factor, not the 0.03 difference in median TM-score. ### AlphaFold3 and complex prediction Protein complexes are where monomer accuracy meets a harder problem. AF2's accuracy decreases with the number of chains, and GPU memory limits the size of predictable complexes. One response is assembly from subcomponents. The MoLPC approach predicted structures of subcomplexes and assembled them using Monte Carlo tree search, correctly assembling 91 of 175 complexes with 10 to 30 chains, with a median TM-score of 0.51 and 30 highly accurate complete assemblies (TM-score at or above 0.8, about 33 percent), driven by a scoring function called mpDockQ that distinguishes complete assemblies and estimates their accuracy. Symmetric complexes assembled well, while asymmetric complexes remained challenging, and the method is available as a Colab notebook [11]. A companion sequential-assembly strategy extended this line of work for large complexes [12]. This scaling problem generalizes. MultimerMapper was built precisely because cloud implementations of AlphaFold broadened access to multimer predictions, but no non-AI tools existed to systematically interpret ensembles of overlapping predictions. It uses statistics and graph theory to infer probable stoichiometries, highlight higher-order subassemblies, and identify alternative interaction modes and conformational changes associated with the presence or absence of specific partners in the modeling context, and it is cross-platform and freely available [13][14]. If you predict an A:B complex and separately an A:B:C complex and the A:B interface shifts, MultimerMapper is designed to make that context dependence visible and testable rather than anecdotal. Docking pipelines show a third pattern, hybrid adoption. The HDOCK team competed in CAPRI rounds 47 through 55 (CAPRI is the community-wide Critical Assessment of PRediction of Interactions for complex modeling). They began with a hybrid of template-based and ab initio docking, integrated AlphaFold into their pipeline starting from Round 53, and after learning from other Round 54 participants refined their AlphaFold sampling strategy, which significantly improved accuracy in Round 55 [15]. The lesson for practitioners is that AlphaFold is now a component inside docking pipelines, not a wholesale replacement of them. ### AlphaFold Server and ColabFold access routes ![A three column comparison of the hosted AlphaFold Server, ColabFold notebooks and a local install across setup, hardware, control and best use.](/article-images/illustrations/protein-structure-prediction-tools-comparison-access-routes.webp) Practical access matters as much as accuracy, and this is where the alphafold server question arises. You have three realistic routes. 1. **Hosted web servers.** DeepMind's AlphaFold Server accepts sequences in a browser and returns predictions without local hardware, which is the lowest-friction route and the one most newcomers should start with. Cloud notebooks occupy a middle ground. The MoLPC complex-assembly workflow, for instance, is distributed as a Colab notebook that runs on Google's infrastructure [11]. 2. **ColabFold and similar notebooks.** ColabFold wraps AF2 with fast MMseqs2-based MSA generation so you can predict from a browser session with GPU acceleration, accepting a single FASTA or a comma-separated multi-chain FASTA for complexes. 3. **Local installation.** Full AF2 locally requires the genetic databases (UniRef, Mgnify, PDB-derived templates) and one or more GPUs. You gain reproducibility, custom MSAs, and control over random seeds. You pay in setup and storage. A short alphafold tutorial for the ColabFold route looks like this. ```bash # Install (after installing ColabFold's conda package or using the notebook directly) colabfold_batch --help # confirm the binary is on PATH # Predict a monomer from a FASTA file using MMseqs2 for the MSA colabfold_batch input.fasta ./results/ # Predict a heterodimer: put both chains in one FASTA, separated by a colon line # >complex|two chains # METHISCHAINONE # METHISCHAINTWO # Re-rank multiple seeds/models: check the per-model pLDDT summary table # and the *_scores.json for PAE matrices. ``` Interpret the output the same way regardless of route. Rank predictions by mean pLDDT for monomers and by PAE between chains for complexes, and never treat the top-ranked model as ground truth without an independent quality check. ## Side-by-Side Comparison Table This table is the core of the protein structure prediction tools comparison. Treat the strengths and limits as tendencies, not guarantees, for any individual target. | Tool | Method class | Input requirements | Typical strength | Main weakness | Best used for | |--|--|--|--|--|--| | AlphaFold2 (AF2) | Deep learning, MSA-based | FASTA sequence, MSA and template databases (local) or MMseqs2 web service | Highest median accuracy in recent benchmarks (TM-score 0.96, GDT-TS 94 percent, RMSD 1.30 Å on 1,337 post-training PDB chains) [10] | Degrades with shallow MSAs and orphan proteins [4], weak for disordered regions, single dominant state | Fast, accurate monomer models for most proteins with homologs | | ESMFold | Language model, alignment-free | FASTA sequence only | 10 to 30 times faster than AF2, TM-score 0.95, competitive on many targets [10] | Slightly lower median accuracy than AF2 (GDT-TS 90 percent) [10] | High-throughput screens, proteome-scale annotation, quick looks | | OmegaFold | Language model plus geometric folding | FASTA sequence only | Fast, TM-score 0.93, notably strong on de novo designed proteins [10] | Lower median accuracy on natural proteins than AF2 [10] | Designed proteins, no-homolog fast screens | | MODELLER | Homology modeling, restraint-based | Target-template alignment | Ligand-aware, multi-model sampling, integrates into hybrid pipelines (AlphaMod combines AF2 with MODELLER) [5] | Requires a good template and alignment, accuracy falls with low identity | Refining AF2 models, ligand-bound contexts, engineering cycles | | SWISS-MODEL / Prostruc | Homology modeling web/open tools | FASTA sequence, automated template search | Accessible with minimal expertise, built-in validation via TM-align and QMEANDisCo [6] | Limited to template quality, less control than MODELLER | Quick template-based models, teaching, small batches | | I-TASSER | Threading plus fragment assembly | FASTA sequence | Works where templates are remote, ranked well across CASP assessments [3] | Slower, template-dependence can mislead on novel folds | Remote-homology targets, fold assignment | | Rosetta / trRosetta / Robetta | Physics-based and neural-restraint hybrid | Sequence, optionally restraints or RoseTTAFold predictions | Explicit energy optimization, flexible restraints, refinement of models from any source [8][3] | Slow, parameterization expertise required | Refinement, design, restrained modeling | | AlphaFold3 / complex pipelines | Deep learning for complexes, assembly methods | Multi-chain FASTA or subcomplex predictions | Accurate interfaces for well-behaved complexes, assembly of 10 to 30 chain systems from subcomponents (91 of 175 assembled, median TM-score 0.51) [11] | Accuracy and memory degrade with chain count, asymmetric assemblies hard [11] | Protein-protein interactions, stoichiometry exploration with ensemble analysis [13][14] | ## How They Differ on the Criteria That Decide Real Choices ![A yes or no triage path that starts from whether homologs exist and ends at a first predictor plus a check.](/article-images/illustrations/protein-structure-prediction-tools-comparison-tool-choice-triage.webp) ### Accuracy versus speed The 2025 benchmark of AF2, ESMFold, and OmegaFold gives the cleanest published numbers for this trade-off. AF2 leads on every median metric but costs the most compute. The same authors found the differences negligible for many proteins and built classifiers to predict when the cheap tools suffice, which reframes the question from which tool is best to which tool is best for this sequence [10]. A practical policy is to run an alignment-free predictor first across a whole dataset, then escalate the low-confidence subset to AF2. ### Data requirements: MSAs, templates, and nothing at all Traditional homology modeling is template-first. Threading is fold-library-first. AF2 is MSA-first with template assist. ESMFold and OmegaFold are sequence-only. The orphan-protein benchmark literature shows why this matters. AF2 performs unsatisfactorily as MSA depth decreases, and the two response strategies are MSA-enhanced models (improving poor MSAs through knowledge distillation and generation) and MSA-free models (learning structure from pretrained language representations directly) [4]. If your protein comes from a poorly sampled lineage, a metagenome, or a synthetic design, the sequence-only tools deserve a genuine test rather than a reflexive AF2 run. Also note the deeper point from the TemPred work. The meaning of a known structure depends on the similarity method used to find it, and templates found by unconventional criteria sometimes beat conventional ones, supporting combined approaches [9]. Template search is not settled science. ### Complexes and context Monomer benchmarks flatter every tool. Complexes expose differences. AF2-based multimer prediction is strong but chain-count limited, and assembly approaches recover large systems only partially, with symmetry helping and asymmetry hurting [11]. Ensemble interpretation adds another layer. Predictions vary with modeling context, meaning which partners you include in the input, and MultimerMapper formalizes the analysis of those variations to infer stoichiometry and alternative interaction modes [14]. If your biology depends on a specific interface, predict the interface in more than one context and compare. Docking pipelines converged on hybrids for a reason. The AlphaFold-enhanced HDOCK experience across CAPRI rounds 47 through 55 shows iterative gains from blending AlphaFold with classical template and ab initio docking rather than discarding them [15]. ### Quality assessment: judging models without a reference Every prediction needs a score you did not generate yourself. The standard structural metrics are TM-score (template modeling score, a global fold-similarity measure sensitive to the alignment core), GDT_TS (global distance test total score, the percentage of residues under increasing distance cutoffs), and lDDT (local distance difference test, a local, superposition-free measure) [3]. For predicted structures you also use self-consistency signals: pLDDT and PAE from AF2, plus external validators. The AlphaMod pipeline is instructive here. It incorporated and compared a set of different quality assessment tools and combined their outputs into a composite score (BORDASCORE) that correlates meaningfully with GDT_TS, enabling selection of optimal models when no reference structure exists [5]. That is the operating condition for almost all real projects, so a composite of independent validators beats trust in any single number, including the model's own confidence. ## Worked Scenarios ### Scenario 1: A soluble enzyme from a well-studied organism You have a 320-residue hydrolase from a model bacterium with thousands of homologs. Run AF2 (ColabFold or server). Expect a high-confidence model, plausibly near the benchmark medians above. Then run one homology model to a ligand-bound template for active-site geometry, validate both with an independent tool, and proceed. If the AF2 pLDDT is high across the catalytic domain and the homology model agrees, you are done. This is the case where the answer to the best protein structure prediction tools comparison question is AF2 first, traditional tools for context. ### Scenario 2: An orphan protein from a metagenome Your 180-residue protein returns no significant homologs. AF2 confidence will likely be uneven, and the orphan-protein literature documents AF2's degradation at shallow MSA depth [4]. Run ESMFold or OmegaFold as well, since alignment-free methods sometimes outperform on this regime [10][4]. Model with both, compare secondary structure and domain predictions, run disorder prediction separately (flDPnn for accuracy and speed, IUPred for very fast screening, per the tutorial comparing 23 disorder tools [16]), and treat any single model as a hypothesis. Consider threading too, since fold recognition can succeed where sequence identity fails [9]. ### Scenario 3: A large symmetric complex You need a 12-chain assembly. Direct monolithic prediction will strain GPU memory and accuracy falls with chain count [11]. Predict subcomponents, assemble with a tree-search approach such as MoLPC, and use mpDockQ to judge completeness and accuracy. Symmetric assemblies fare well, asymmetric ones poorly [11]. Follow with ensemble predictions across contexts and, if the composition is uncertain, use a stoichiometry-inference pipeline [13][14]. Refine critical interfaces with restrained Rosetta or MD if downstream work demands it. ### Scenario 4: A viral protein with no full-length template The HCVcp study is the template for this situation. No adequate full-length templates existed, so the authors performed domain-based homology modeling in MOE with templates found per domain through NCBI and PDB searches, assembled domains, and compared against AF2, Robetta-RoseTTAFold, and trRosetta, with MD simulations to refine and compare structures [8]. The transferable protocol is to decompose the problem, model each piece with the method that fits it, assemble, and use cross-method agreement plus MD as your quality gate. ### Scenario 5: A structure for molecular docking This is the scenario with the sharpest documented caveat. The APOE study found that AF2 models of apolipoprotein E conformationally differ significantly from the available NMR structure (2L7B) and from circular-dichroism-derived structures. The epsilon4 isoform lacked the R61 and E255 salt bridge, and the epsilon2 and epsilon3 isoforms showed extensive interdomain interaction networks. The authors conclude their findings challenge the benefit of using AF2 models as starting conformations for [molecular docking](/knowledge/bioinformatics/docking-algorithms-autodock-glide-and-beyond) in this case [17]. APOE is an extreme case, being lipid-associated and conformationally plastic, but the operational rule generalizes. For flexible or lipid-associated proteins, validate the AF2 model against whatever experimental data exists before docking, and consider MD relaxation or template-based models as alternatives. The KLK11 drug-discovery workflow chose homology modeling with server validation before virtual screening for similar pragmatic reasons [7]. ## Common Mistakes and Limitations 1. **Reading pLDDT as global accuracy.** pLDDT is per-residue local confidence. A model can average 90 pLDDT with a catastrophically wrong interdomain arrangement that only the PAE matrix reveals. Check PAE between domains before you trust a two-domain model. 2. **Treating the top-ranked model as the structure.** AF2 emits multiple models. Rank by mean pLDDT for monomers and inter-chain PAE for complexes, but confirm with independent validators. Composite scoring approaches such as BORDASCORE exist precisely because no single number suffices without a reference [5]. 3. **Ignoring MSA depth.** If your MSA has a handful of sequences, AF2's advantage largely evaporates and sequence-only tools become competitive [4]. Report MSA depth alongside your model. 4. **Docking into a rigid single-state AF2 model.** Flexible, lipid-associated, and multi-state proteins are documented failure cases for naive docking into AF2 conformations [17]. Relax, ensemble, or template. 5. **Forgetting disordered regions.** pLDDT near the low range on a stretch of your model often means intrinsic disorder, not a modeling error. Use dedicated disorder predictors rather than pruning or over-interpreting those segments [2][16]. 6. **Comparing tools on your own target with no protocol.** Ad hoc comparisons produce irreproducible conclusions. Standardized benchmarking frameworks exist for exactly this reason, including an nf-core framework built for systematic comparison of alternative tools, demonstrated on the MSA software that feeds structure prediction in the first place [18]. MSAs are NP-hard, so different aligners give different inputs and therefore different AF2 results. Fix your alignment source or vary it deliberately. 7. **Assuming one tool fits all contexts.** The NF-core authors state the general problem plainly. Many bioinformatics problems admit numerous heuristic solutions where no single approach consistently outperforms all others [18]. The same holds for structure prediction. 8. **Using AF2 output for claims about mechanism without experimental support.** Predicted models are hypotheses. The APOE case shows that a prediction can disagree with existing NMR and spectroscopy data in biologically meaningful ways [17]. Cross-check against any experimental structure, cross-linking data, or mutagenesis available. One final scope note for individual projects. Results for any specific protein depend on its homolog family, oligomeric state, and conformational behavior, so a published benchmark trend is a starting prior, not a verdict on your target. ## Frequently Asked Questions ### Is AlphaFold accurate enough to replace experimental structure determination? For well-ordered globular domains with good homologs, AF2's benchmark accuracy is close enough to experimental that predicted models are standard starting points for many protein scientists [2][10]. It does not replace experiments for ligand-bound states, alternative conformations, disordered regions, or unusual environments, all documented weak points above. ### Do I still need homology modeling tools like MODELLER or SWISS-MODEL? Yes. Homology modeling remains useful for ligand-aware models, multi-state sampling, and refinement, and hybrid pipelines that couple AF2 with MODELLER are actively developed and validated against AF2 benchmarks [5][7][6]. ### What is the difference between the AlphaFold Server, ColabFold, and running AlphaFold locally? The hosted server is a browser route with no local hardware, ColabFold is a notebook or command-line wrapper with fast MMseqs2 MSA generation, and a local install gives full control over databases, MSAs, and seeds at the cost of setup and GPU requirements. Complex assembly workflows are also distributed as Colab notebooks [11]. ### When should I use ESMFold or OmegaFold instead of AlphaFold2? When throughput matters or MSAs are weak. They run 10 to 30 times faster than AF2 with a small median accuracy penalty, they are competitive for many proteins, and they are strong on de novo designed proteins [10]. ### What do pLDDT and PAE mean and how should I use them? pLDDT is a per-residue estimate of local model accuracy on a 0 to 100 scale, and PAE estimates positional error between pairs of residues, which is the key diagnostic for domain packing and inter-chain interfaces. Use pLDDT to rank monomer models and PAE to judge interfaces, then confirm with independent metrics such as TM-score, GDT_TS, or lDDT against any available reference [3]. ### Can AlphaFold predict intrinsically disordered proteins and large complexes? Not reliably in the way it handles ordered monomers. Disordered regions are a recognized open frontier rather than a solved problem [2], and dedicated disorder predictors should be used for those segments [16]. Large complexes require assembly strategies from predicted subcomponents, and even then median accuracy is modest with asymmetric assemblies remaining hard [11]. ## Sources 1. [Starting at Go: Protein structure prediction succumbs to machine learning](https://pubmed.ncbi.nlm.nih.gov/37732752/) 2. [Solution of the protein structure prediction problem at last: crucial innovations and next frontiers.](https://pubmed.ncbi.nlm.nih.gov/36644294/) 3. [AI-Driven Deep Learning Techniques in Protein Structure Prediction](https://pubmed.ncbi.nlm.nih.gov/39125995/) 4. [Improved structure-related prediction for insufficient homologous proteins using MSA enhancement and pre-trained language model.](https://pubmed.ncbi.nlm.nih.gov/37321965/) 5. [An automated pipeline integrating AlphaFold 2 and MODELLER for protein structure prediction.](https://pubmed.ncbi.nlm.nih.gov/38047234/) 6. [Prostruc: an open-source tool for 3D structure prediction using homology modeling.](https://pubmed.ncbi.nlm.nih.gov/39717221/) 7. [An In Silico Design, Simulation, Virtual Screening, and Evaluation of Natural Products as Inhibitors of Breast Cancer-Causing Kallikrein11 Protein and Comparison of Binding Affinities with Approved Drugs.](https://pubmed.ncbi.nlm.nih.gov/41503904/) 8. [Comparison, Analysis, and Molecular Dynamics Simulations of Structures of a Viral Protein Modeled Using Various Computational Tools.](https://pubmed.ncbi.nlm.nih.gov/37760106/) 9. [TemPred: A Novel Protein Template Search Engine to Improve Protein Structure Prediction](https://pubmed.ncbi.nlm.nih.gov/37018272/) 10. [Balancing speed and precision in protein folding: a comparison of AlphaFold2, ESMFold, and OmegaFold.](https://pubmed.ncbi.nlm.nih.gov/41608648/) 11. [Predicting the structure of large protein complexes using AlphaFold and Monte Carlo tree search](https://pubmed.ncbi.nlm.nih.gov/36224222/) 12. [Predicting the structure of large protein complexes using AlphaFold and sequential assembly](https://www.semanticscholar.org/paper/aef682f643d84105cd9fd571cf44b1a4a299f378) 13. [Context-Dependent Protein Structure Prediction Analysis and Stoichiometry Inference with MultimerMapper](https://doi.org/10.1101/2025.10.24.684463) 14. [Context-dependent protein structure prediction analysis and complex stoichiometry inference with MultimerMapper](https://pubmed.ncbi.nlm.nih.gov/42923437/) 15. [Protein Complex Structure Prediction With AlphaFold-Enhanced HDOCK in CAPRI Rounds 47-55.](https://pubmed.ncbi.nlm.nih.gov/40167205/) 16. [Tutorial: a guide for the selection of fast and accurate computational tools for the prediction of intrinsic disorder in proteins.](https://pubmed.ncbi.nlm.nih.gov/37740110/) 17. [Tackling APOE's structural challenges via in silico modeling in the era of neural networks: can AlphaFold II help circumvent the problem of lacking full-length protein structure?](https://pubmed.ncbi.nlm.nih.gov/39447622/) 18. [An nf-core framework for the systematic comparison of alternative modeling tools: the multiple sequence alignment case study.](https://pubmed.ncbi.nlm.nih.gov/40746377/)